The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-13D CML: Basic/Clinical

Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Hideo Tanaka (Department Hematology& Oncology, Hiroshima City Asa Hospital, Japan)

[OS1-13D-5] Can bosutinib overcome intolerance and resistance to preceding TKIs in patients with CML-CP?

Daisuke Koyama, Rie Ito, Koji Umemura, Satomi Yamamoto, Naoto Imoto, Shingo Kurahashi, Isamu Sugiura (Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password